Atara Biotherapeutics, Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Atara Biotherapeutics, Inc. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Option Exercise | M | 11.00 | 11,406 | 125,466 | 3,125 | |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Option Exercise | M | 22.72 | 32,500 | 738,400 | 32,500 | |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Option Exercise | M | 25.15 | 28,848 | 725,527 | 11,194 | |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 41.10 | 11,103 | 456,333 | 156,071 | 167.2 K to 156.1 K (-6.64 %) |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 40.40 | 2,800 | 113,120 | 167,174 | 170 K to 167.2 K (-1.65 %) |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 39.53 | 2,170 | 85,780 | 169,974 | 172.1 K to 170 K (-1.26 %) |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 38.23 | 29,980 | 1,146,135 | 172,144 | 202.1 K to 172.1 K (-14.83 %) |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 37.10 | 31,356 | 1,163,308 | 202,124 | 233.5 K to 202.1 K (-13.43 %) |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 36.43 | 22,794 | 830,385 | 233,480 | 256.3 K to 233.5 K (-8.89 %) |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Buy | M | 11.00 | 11,406 | 125,466 | 256,274 | 244.9 K to 256.3 K (+4.66 %) |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Buy | M | 22.72 | 32,500 | 738,400 | 244,868 | 212.4 K to 244.9 K (+15.30 %) |
| Mar 28 2018 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Buy | M | 25.15 | 28,848 | 725,527 | 212,368 | 183.5 K to 212.4 K (+15.72 %) |
| Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.40 | 200 | 7,680 | 206,478 | 206.7 K to 206.5 K (-0.10 %) |
| Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.68 | 1,500 | 56,520 | 206,678 | 208.2 K to 206.7 K (-0.72 %) |
| Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.63 | 2,700 | 98,901 | 208,178 | 210.9 K to 208.2 K (-1.28 %) |
| Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.12 | 1,200 | 49,344 | 210,878 | 212.1 K to 210.9 K (-0.57 %) |
| Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.72 | 3,200 | 127,104 | 212,078 | 215.3 K to 212.1 K (-1.49 %) |
| Mar 27 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.29 | 1,100 | 44,319 | 332,905 | 334 K to 332.9 K (-0.33 %) |
| Mar 27 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 39.76 | 17,227 | 684,946 | 334,005 | 351.2 K to 334 K (-4.90 %) |
| Mar 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 38.83 | 3,000 | 116,490 | 88,762 | 91.8 K to 88.8 K (-3.27 %) |
| Mar 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 41.99 | 3,000 | 125,970 | 91,762 | 94.8 K to 91.8 K (-3.17 %) |
| Mar 19 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.59 | 1,300 | 55,367 | 215,278 | 216.6 K to 215.3 K (-0.60 %) |
| Mar 19 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.75 | 3,100 | 129,425 | 216,578 | 219.7 K to 216.6 K (-1.41 %) |
| Mar 19 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.95 | 1,600 | 68,720 | 219,678 | 221.3 K to 219.7 K (-0.72 %) |
| Mar 19 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.87 | 2,800 | 117,236 | 221,278 | 224.1 K to 221.3 K (-1.25 %) |
| Mar 14 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 46.65 | 300 | 13,995 | 224,078 | 224.4 K to 224.1 K (-0.13 %) |
| Mar 14 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 46.17 | 700 | 32,319 | 224,378 | 225.1 K to 224.4 K (-0.31 %) |